Gopalakrishna Pillai, Ph.D.

Administration - Facult

Professor of Research and CENTERA

Education:
Birla Institute of Technology and Science
Pilani, India
B. Pharm and M. Pharm 

The University of British Columbia
Vancouver, Canada
MSc and Ph.D. in Pharmaceutical Sciences 

Fields of Interest:
Developing analytical methods for drug analysis in Bio fluids for study of Pharmacokinetics, drug metabolism, and bioequivalence evaluation. Targeted drug delivery of anticancer, anti-inflammatory, and metal chelating agents. Stereospecific assay methods and stereoselective drug disposition.

Contact information:
Email: gpillai@sullivan.edu
Office phone: 502-413-8951
Office fax: 502-515-4669

Biography

Dr.Pillai received his B.Pharm (1965) and M.Pharm (1967) from Birla Institute of Technology and Science, Pilani, Rajasthan, India and MSc (1981) and PhD (1984) from the University of British Columbia (UBC), Vancouver, BC, Canada. Dr.Pillai was on the faculty of the College of Pharmaceutical Sciences, Manipal, India from 1967-1975, in the School of Pharmacy, Addis Ababa University, Ethiopia from 1975-1978, at the university of British Columbia , Vancouver from 1978-1984 as a graduate student, in the college of Pharmacy, Manipal, India as a professor of Pharmaceutics from 1984-1991, at the Jordan University of Science and Technology, Irbid, Jordan from 1991-1998 and at the University of the West Indies, Trinidad from 1998-2009 as professor and Director of the School of Pharmacy, UWI. While in Trinidad, Dr.Pillai also served as a member of the Drug Advisory committee, Ministry of Health, Government of Trinidad & Tobago, an honorary appointment by the Minister of Health. Dr.Pillai represented Trinidad at the PAHO/WHO sponsored conferences on “Pharmaceutical education in the Caribbean” in Barbados, Bahamas, Buenos Aires (Argentina) and Montevideo (Uruguay). Dr.Pillai supervised the research work of 14 post graduate students (M.Pharm & M.Phil) and three PhD students. His area of research include formulation and evaluation of Niosomes (surfactant vesicles) as targeted drug delivery systems for anticancer agents, anti-inflammatory agents and metal chelating agents, developing analytical methods (high resolution Gas chromatography with capillary columns, analysis of enantiomeric mixtures for study of stereospecific drug disposition and HPLC) and evaluation of bioequivalence of generic drug products. He has 56 publications in international Journals and 39 abstracts and has been the recipient of many research grants from several agencies.